Biotech · Private company · Los Altos, CA, US

Cardiac Rsk3 Inhibitors, LLC

Track this companyFree. Adds Cardiac Rsk3 Inhibitors, LLC to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards2

CRI-103 gene therapy as Investigational New Drug for Dilated CardiomyopathyFiscal year 2026 · $1.2MNIH RePORTER 2R44HL167349-03 · fetched Nov 12, 2026
RSK3 Anchoring Disruptor Therapy for Heart FailureFiscal year 2024 · $2MNIH RePORTER 5R44HL167349-02 · fetched Nov 12, 2026